Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2014

Jan 14, 2014

6990_dirs_2014-01-14_23635f32-4a16-4311-9c0c-045d2169d9eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2014-01-10

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-10 Common Stock S 2000 $4.250 Disposed 1783148 Direct
2014-01-13 Common Stock S 67850 $4.296 Disposed 1715298 Direct

Footnotes

F1: The sales reported on this Form 4 were affected pursuant to automatic selling under Rule 10b5-1 trading plan adopted by the reporting person.